SEC Form 4 · accession 0000899243-17-003648
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Nicholson
Officer — SVP & Chief Operating Officer
Period of report
Feb 10, 2017
Accepted (ET)
Feb 10, 2017 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2017 | M | 45,000 | $4.65 | A | 185,326 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.65 | Feb 10, 2017 | M | 45,000 | D | — | Feb 22, 2017 | Common Stock | 45,000 | 0 | D |
Explanation of responses
- F1This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised.